Amnisure Fetal Membranes Rupture Test Model FMRT1
Single (Specified) Analyte Controls (Assayed And Unassayed). 510(k) K030849, from N-Dia, Inc. (New York, NY). Product code JJX, class 1.
As of Nov 22, 2026, K030849 is an FDA 510(k) held by N-Dia, Inc., substantially equivalent on Feb 2, 2004 after 322 days, with 1 recall tied to it in FDA's recall database.
- Review time: 322 days
- Recalls: 1
- Cited as a predicate by: 2 devices
The AmniSureâ„¢ ROM (Rupture Of [fetal] Membranes) Test is a rapid, non-instrumented, qualitative immunochromatographic test for the in vitro detection of amniotic fluid in vaginal secretions of pregnant women. AmniSure detects PAMG-1 protein marker of the amniotic fluid in vaginal secretions.
- Rom PlusK110605 · Clinical Innovations, LLC · Nov 23, 2011
- Actim Prom and ControlsK061886 · Medix Biochemica · Jan 25, 2007
| Started | Recall | Status |
|---|---|---|
| Oct 3, 2007 | Z-0120-2008Weak true postive/false negative results: weak true positive or false negatives in ruptured fetal membranes may occur due to a "hook effect" | Terminated |
- Type
- Traditional
- Received
- Mar 17, 2003
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files